Stockscreener 앱 받기
1.91
5.91%
-0.12
시간 외 거래:
1.91
전일 마감가:
$2.03
열려 있는:
$2.04
하루 거래량:
677.42K
Relative Volume:
3.48
시가총액:
$30.70M
수익:
-
순이익/손실:
$-8.29M
주가수익비율:
-2.7286
EPS:
-0.7
순현금흐름:
$-6.47M
1주 성능:
+24.84%
1개월 성능:
+38.41%
6개월 성능:
+46.92%
1년 성능:
+29.93%
1일 변동 폭
$1.812
$2.1999
1주일 범위
$1.54
$2.1999
52주 변동 폭
$0.94
$2.1999
NanoViricides Inc Stock (NNVC) Company Profile
명칭
NanoViricides Inc
전화
203-937-6137
주소
1 Controls Drive, Shelton, CT
NNVC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.91 | 35.38M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-02-11 | 개시 | Midtown Partners | Strong Buy |
NanoViricides Inc 주식(NNVC)의 최신 뉴스
How to build a dashboard for NanoViricides Inc. stockEarnings Performance Report & Risk Controlled Swing Alerts - newser.com
How NanoViricides Inc. stock trades after earningsDollar Strength & Low Risk Investment Opportunities - newser.com
Is NanoViricides Inc. stock undervalued vs historical averagesPortfolio Return Report & Verified High Yield Trade Plans - newser.com
Is NanoViricides Inc. stock a defensive play amid uncertainty2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
How to use Fibonacci retracement on NanoViricides Inc.2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides - Herald Times Reporter
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Norwich Bulletin
NanoViricides to Present Antiviral Drug Pipeline at Spartan Capital Investor Conference - citybuzz -
Why NanoViricides Inc. stock appeals to dividend seekersJobs Report & High Accuracy Swing Entry Alerts - newser.com
Why NanoViricides Inc. stock is upgraded to buy2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - ACCESS Newswire
Can NanoViricides Inc. (NV3P) stock ride next bull market cycleMarket Risk Report & Consistent Income Trade Recommendations - newser.com
Can NanoViricides Inc. stock hit consensus price targetsMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
NanoViricides to present at Spartan Capital Investor Conference 2025 in New York - Proactive financial news
How NanoViricides Inc. (NV3P) stock trades after rate cutsJuly 2025 PreEarnings & Growth-Oriented Investment Plans - newser.com
Combining machine learning predictions for NanoViricides Inc.Trade Volume Summary & AI Powered Buy and Sell Recommendations - newser.com
Will NanoViricides Inc. stock split attract more investorsIPO Watch & Accurate Technical Buy Alerts - newser.com
What MACD trends signal for NanoViricides Inc. stock2025 Top Gainers & Fast Gain Stock Tips - newser.com
Has NanoViricides Inc. found a price floorTrade Performance Summary & Detailed Earnings Play Alerts - newser.com
Using portfolio simulators with NanoViricides Inc. includedInflation Watch & Technical Pattern Alert System - newser.com
NanoViricides, Inc. Has Filed its Annual Report - The Marion Star
NanoViricides Dual Track Clinical Strategy Explained by a Research ReportBroad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses - The Holland Sentinel
NanoViricides targets broad-spectrum virus threats – ICYMI - Proactive financial news
Identifying reversal signals in NanoViricides Inc.2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Detecting support and resistance levels for NanoViricides Inc.Weekly Trade Report & Community Verified Trade Alerts - newser.com
NanoViricides Inc (NNVC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):